Dealing in securities by a director
Super Group Limited
(Incorporated in the Republic of South Africa)
(Registration number: 1943/016107/06)
Share code: SPG
ISIN: ZAE000161832
(“Super Group”)
DEALING IN SECURITIES BY A DIRECTOR
1. In compliance with paragraphs 3.63 to 3.66 of the Listings Requirements,
shareholders are advised that a director of Super Group has, in terms of
the Share Appreciation Right Scheme 2005 (“the Scheme”), been issued
shares in terms of previously accepted grants that have vested.
Shareholder approval of the Scheme was obtained at the 2005 Annual
General Meeting. All rights have conditions attached and are subject to
the rules of the Scheme. The Remuneration Committee approved the grants
and the required clearance in terms of paragraph 3.66 of the Listings
Requirements was obtained.
The Scheme supports the principle of aligning management and shareholder
interests. Performance conditions governing the vesting of these rights
are intended to be stretching but achievable. The performance conditions
are related to headline earnings per share increasing by 2% per annum
above the Consumer Price Inflation Index over the three year performance
period ended 30 June 2013. The grants are conditional upon the
participant remaining employed during the performance period.
The grants that have vested have been awarded in terms of performance
conditions for the Financial Year ended 30 June 2013 and the shares have
been issued to the following director.
Name of director Number of Share Number of Shares Nature of interest
Appreciation Issued (1)
Rights (“SARS”)
C Brown 300 000 234 526 Direct, Beneficial
Date of transfer 18 March 2014
Nature of transaction Issue of shares
Class of securities Ordinary shares
Strike price of SARS R6.10
Strike date 18 March 2014
Exercise Price of SARS R27.9500
Vesting date Following approval by the Remuneration
Committee based on the audited results for
the year ended 30 June 2013
Name of director Number of Share Number of Shares Nature of interest
Appreciation Issued (1)
Rights (“SARS”)
C Brown 200 000 147 764 Direct, Beneficial
Date of transfer 18 March 2014
Nature of transaction Issue of shares
Class of securities Ordinary shares
Strike price of SARS R7.30
Strike date 18 March 2014
Exercise Price of SARS R27.9500
Vesting date Following approval by the Remuneration
Committee based on the audited results for
the year ended 30 June 2013
(1)The number of shares issued is calculated by the total gain on the
SARS, which is the difference between the strike price and the exercise
price multiplied by the number of SARS. The gain is then divided by the
exercise price to determine the number of shares issued.
2. In compliance with paragraphs 3.63 to 3.66 of the Listings Requirements,
Super Group advises that it has been informed of the following dealings
in its shares:
Director Colin Brown
Company Super Group
Date of transaction 19 March 2014
Nature of transaction Sale of shares on market
Nature of interest Direct, beneficial
Class of securities Ordinary shares
Clearance to deal Yes
Number of shares sold 311 765
Highest Price R28.4700
Lowest Price R28.2000
Volume Average Weighted R28.2545
Price
Total value of
transaction R8 808 764.71
Director Colin Brown
Company Super Group
Date of transaction 20 March 2014
Nature of transaction Sale of shares on market
Nature of interest Direct, beneficial
Class of securities Ordinary shares
Clearance to deal Yes
Number of shares sold 70 525
Highest Price R28.0600
Lowest Price R27.9500
Volume Average Weighted R27.9734
Price
Total value of
transaction R1 972 822.60
The required clearance per paragraph 3.66 of the Listings Requirements
was obtained.
The transactions are not a reflection of his views on the Group and
simply represent diversification of investments.
Sandton
20 March 2014
Sponsor: Deutsche Securities (SA) Proprietary Limited
Date: 20/03/2014 03:45:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.